Investor Readiness Program: Apply by July 31st
Life Sciences BC’s annual Investor Readiness Program* (IRP) runs from October to March and pairs 10 early-stage British Columbian (BC) small and mid-size enterprises (SMEs) and 10 entrepreneurs-in-residence (EIRs) to support the SMEs to become investor-ready.
Completion of Inaugural Visiting Scientist Program
We are very pleased to announce the successful completion of the inaugural ATM Visiting Scientist Program with Dr. Stefan Burdach. Dr. Burdach was visiting from March to June of 2022 from the Translational Pediatric Cancer Research Action, Institute of Pathology and Children’s Cancer Research Center, Department of Pediatrics at Technical University of Munich School of […]
The LSI becomes a GREx: announcing the launch of the Biological Resilience Initiative
We are proud to announce that The Life Sciences Institute has been designated a UBC Global Research Excellence Institute (GREx) and is ready to formally launch the Biological Resilience Initiative (BRI).
BioInnovation Scientist Program for Early-Career Researchers
The adMare Academy builds talent by training highly-qualified personnel—from undergrads to industry executives—who will drive the growth of the Canadian life sciences industry. Our ultimate goal? To ensure that you have the knowledge, skills, and network to start or grow your career in the Canadian life sciences sector, and that Canadian companies have the talent they need to succeed today and in the future.
BC invests $25M into new School of Biomedical Engineering Facility
To promote innovative health care and medical advancements for the future, the Government of British Columbia has invested $25 million into the construction of a new building for the School of Biomedical Engineering.
The ATM receives funding from the BC Ministry of Advanced Education and Skills Training to develop a new micro-credential in Regulatory Affairs in the Life Sciences
UBC’s Academy of Translational Medicine (ATM) is excited to announce that its proposal, Micro-credentials in Regulatory Affairs for the Life Sciences, has been awarded $157,093 by the BC Ministry of Advanced Education and Skills Training (MAEST).
UBC’s Academy of Translational Medicine and UBC Extended Learning offer a new micro-certificate in Regulatory Affairs in the Life Sciences
With financial support from the BC Ministry of Advanced Education and Skills Training, the UBC Academy of Translational Medicine (ATM) has partnered with UBC Extended Learning to offer the UBC Micro-certificate in Regulatory Affairs for the Life Sciences.
Establishment of the ATM Education Advisory Council
The creation of the Academy of Translational Medicine (ATM) Education Advisory Council is a vital milestone to implementing the ATM’s education platform to support BC and Canada’s translational medicine ecosystem.
Dr. Pieter Cullis awarded 2022 Tang Prize for contributions to COVID-19 mRNA vaccines
UBC Medicine professor Dr. Pieter Cullis has been awarded the 2022 Tang Prize in Biopharmaceutical Science for his work developing the lipid nanoparticle technology that enabled mRNA-based COVID-19 vaccines.